Clinical Trial Update: Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL [Phase 3]

View source ↗

Summary

Phase 3 trial update on STR001-IT and STR001-ER for acute hearing loss reports on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss

Drugs mentioned

• STR001-ER
• STR001-IT

Snippet

Sponsor: Strekin AG | Conditions: Acute Hearing Loss | Phase 3 | Status: COMPLETED